Study on the pathogenesis of progressive vitiligo

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033961

Enrollment

Unknown

Registered

2020-06-19

Start date

2020-06-05

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

vitiligo group:Nil

normal control group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with progressive vitiligo; 2. Know and agree to participate in the study, in which the minor patients need to obtain the informed consent of their guardians; 3. The age and sex of patients are unlimited.

Exclusion criteria

Exclusion criteria: Patients with mental / cognitive disorders.

Design outcomes

Primary

Measure	Time frame
number of immune cells;Cytokine level;Expression of pathogenesis related proteins;Clinical test index;	—

Countries

China

Contacts

Public ContactGuangpu Luo

Dermatology Hospital of Southern Medical University

102931@163.com+86 020-83028343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026